Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Severe Influenza (FLUDEX)
NCT06528444Phase 3Recruiting
- Sponsor
- ISABIAL
- Start
- Oct 2024
- Primary completion
- Oct 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Placebo with Dexamethasone (2 arms). Primary endpoint: Percentage of patients hospitalized at 10 days. Started Oct 2024; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06528444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06528444.